LONG-TERM IMPACT OF GRASS-POLLEN (GP) SUBLINGUAL IMMUNOTHERAPY TABLET (SLIT) ON ALLERGIC RHINITIS (AR) AND ON ALLERGIC ASTHMA (AA) ONSET AND PROGRESSION

被引：0
|
作者：
Devillier, P. [1 ]
Molimard, M. [2 ]
Demoly, P. [3 ]
Ansolabehere, X. [4 ]
Bardoulat, I [4 ]
Coulombel, N. [4 ]
Maurel, F. [5 ]
Le Jeunne, P. [4 ]
机构：
[1] Hop Foch, UPRES EA220, Suresnes, France
[2] CHU Bordeaux Univ, Bordeaux, France
[3] Dept Pulmonol, Montpellier, France
[4] QuintilesIMS, Paris 2, France
[5] QuintilesIMS, La Def, France
来源：
VALUE IN HEALTH | 2017年 / 20卷 / 09期
关键词：
D O I：
10.1016/j.jval.2017.08.1457
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PRS2
引用
收藏
页码：A639 / A640
页数：2
相关论文
共 50 条
  • [21] Real-World Adherence and Evidence of Subcutaneous and Sublingual Immunotherapy in Grass and Tree Pollen-Induced Allergic Rhinitis and Asthma
    Vogelberg, Christian
    Brueggenjuergen, Bernd
    Richter, Hartmut
    Jutel, Marek
    PATIENT PREFERENCE AND ADHERENCE, 2020, 14 : 817 - 827
  • [22] Sublingual Immunotherapy for Allergic Rhinitis Is 2-Year Treatment Sufficient for Long-term Benefit?
    Cox, Linda S.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 317 (06): : 591 - 593
  • [23] Impact of grass pollen sublingual immunotherapy tablets on allergic rhinitis and asthma: Methodological aspects of a real-life, retrospective database analysis performed in France
    Devillier, P.
    Demoly, P.
    Ansolabehere, X.
    Coulombel, N.
    Molimard, M.
    ALLERGY, 2018, 73 : 622 - 623
  • [24] Long-Term Treatment with 300IR 5-Grass Pollen Sublingual Tablet in Grass Pollen Allergic Subjects: Safety Outcome Year after Year
    Golden, David B. K.
    Fahrenholz, John M.
    Renahan, Kevin E.
    Khairallah, Sandrine
    Abiteboul, Kathy
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2017, 139 (02) : AB60 - AB60
  • [25] Grass pollen allergen immunotherapy provides long-term relief of allergic rhinitis and asthma in patients of all age classes: a real world dataset analysis
    Gerstlauer, M.
    Zieglmayer, P.
    Richter, H.
    Kreuzberg, U.
    Hadler, M.
    Devillier, P.
    ALLERGY, 2023, 78 : 20 - 21
  • [26] Long-term Safety Of A 300IR Sublingual Tablet Of 5-grass-pollen Allergen Extract In Adults With Grass-pollen-induced Allergic Rhinoconjunctivitis
    Didier, A.
    Worm, M.
    Horak, F.
    Malling, H.
    Montagut, A.
    Zeldin, R. K.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2012, 129 (02) : AB248 - AB248
  • [27] Treatment with grass pollen slit tablets is associated with long-term relief of allergic rhinitis: A retrospective real-life dataset analysis
    Heinrich, J.
    Zielen, S.
    Wahn, U.
    Richter, H.
    Devillier, P.
    ALLERGY, 2017, 72 : 375 - 375
  • [28] Sublingual immunotherapy provides long-term relief in allergic rhinitis and reduces the risk of asthma: A retrospective, real-world database analysis
    Zielen, S.
    Devillier, P.
    Heinrich, J.
    Richter, H.
    Wahn, U.
    ALLERGY, 2018, 73 (01) : 165 - 177
  • [29] Long-term impact of 300 IR 5-grass pollen sublingual tablet on quality of life in adults with allergy to grass pollen
    Didier, A.
    Horak, F.
    Malling, H.
    Montagut, A.
    Abiteboul, K.
    Zeldin, R.
    ALLERGY, 2012, 67 : 409 - 409
  • [30] The SQ HDM SLIT-tablet is well tolerated in adults with HDM respiratory allergic disease (HDM allergic asthma (AA) and/or allergic rhinitis (AR)): evidence from 2500 subjects in 4 clinical trials
    Emminger, W.
    Calderon, M.
    Maloney, J.
    Fogh B, Svanholm
    Fejerskov, P.
    Hernandez, D.
    ALLERGY, 2015, 70 : 116 - 116
12345